Company Filing History:
Years Active: 2003-2004
Title: Richard E Parker: Innovator in Prostaglandin Delivery
Introduction
Richard E Parker is a notable inventor based in Spring Hill, TN (US). He has made significant contributions to the field of medicine, particularly in the delivery of benzindene prostaglandins. With a total of 2 patents, Parker's work has the potential to improve treatment methods for various medical conditions.
Latest Patents
Parker's latest patents include a method for delivering benzindene prostaglandins by inhalation. This method discusses the administration of a benzindene prostaglandin known as UT-15, which has shown unexpectedly superior results when delivered by inhalation compared to parenteral administration in sheep with induced pulmonary hypertension. Another patent focuses on treating peripheral vascular disease by administering benzindene prostaglandins through inhalation, reiterating the effectiveness of UT-15 in similar conditions.
Career Highlights
Richard E Parker is associated with United Therapeutics Corporation, where he continues to innovate in the field of drug delivery systems. His work is pivotal in advancing therapeutic options for patients suffering from pulmonary hypertension and peripheral vascular diseases.
Collaborations
Parker has collaborated with notable colleagues such as Gilles Cloutier and James Crow, contributing to a dynamic research environment that fosters innovation and development in medical treatments.
Conclusion
Richard E Parker's contributions to the field of prostaglandin delivery highlight his role as an influential inventor. His innovative methods have the potential to transform treatment approaches for patients with serious health conditions.